Lipitor 5 mg (Atorvastatin Calcium Trihydrate)

Adult dosage

Atorvastatin can be administered once daily at any time, regardless of meals. The recommended initial dosage is 5 mg or 10 mg once daily, and for patients requiring greater reductions in LDL cholesterol, it may be initiated at 20 mg or 40 mg once daily. The dosage range is 5 to 80 mg once daily. The initial and maintenance dosages should be individualized based on treatment goals and patient responses within 2 to 4 weeks.

If any abnormal muscle symptoms appear or muscle enzyme levels significantly increase, treatment should be discontinued. Especially if serious myopathy or rhabdomyolysis is suspected, treatment should be stopped immediately. Patients with severely impaired liver function, pregnant women, lactating women, and children under 10 years old should not use this medication. Caution is required for patients with a history of alcohol addiction or liver disease, as well as for those with a history of muscle-related diseases or elderly patients. If symptoms such as muscle pain, muscle weakness, or fatigue appear during treatment, notify a physician immediately. If symptoms indicative of liver dysfunction, such as nausea, vomiting, or malaise occur, discontinue use and seek medical attention. Women of childbearing age must use appropriate contraception while taking this medication, and if pregnancy is confirmed, the medication should be stopped immediately. This drug has many interactions with other medications, so inform the doctor or pharmacist about any other medications being taken. In particular, co-administration with certain antibiotics, antifungals, antivirals, grapefruit juice, etc., may increase blood concentration, raising the risk of side effects. Regular blood tests and liver function tests should be conducted to check for abnormalities during treatment. If muscle pain or weakness is severe or if muscle enzyme levels significantly rise, treatment should be stopped and a physician consulted. Children and elderly patients should be monitored more closely during treatment. There is no specific antidote for overdose; symptomatic treatment should be provided, and liver function and muscle enzyme levels should be tested. This medication should be kept out of the reach of children and stored in the original container to prevent misuse and degradation.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, severe allergic reactions, severe rash accompanied by high fever, blisters, skin peeling, oral/ocular mucosal pain, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities with cough and fever, breathing problems, yellowing of the skin or eyes (jaundice), severe lethargy, liver abnormalities (jaundice), sudden and

Mild side effects

• Constipation
• diarrhea
• nausea
• vomiting
• hypertension
• hypotension
• obstructive cholelithiasis
• dehydration
• weakness
• malaise

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is best to keep it at room temperature between 1 and 30 degrees Celsius.

Appearance

White oval film-coated tablet

Package unit

Bottle - 30 tablets/bottle, PTP - 30 tablets/PTP [10 tablets/PTP packaging x 3]